Skip to main content
European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

European Glaucoma Research Training program - Advancing the Approach of Advanced glaucoma

Descripción del proyecto

DE EN ES FR IT PL

Un programa de formación sobre tratamientos para el glaucoma

El glaucoma es una afección ocular asociada a una lesión del nervio óptico que conecta el ojo con el encéfalo. Si no se trata a tiempo, el glaucoma progresa y puede causar una pérdida de visión. La misión del proyecto EGRET-AAA, financiado por las Acciones Marie Skłodowska-Curie, es desarrollar tratamientos innovadoras para el glaucoma. El consorcio ofrece un programa de doctorado conjunto para investigadores noveles, con el fin de investigar la terapia génica y los métodos basados en células madre para tratar el glaucoma mediante la tecnología de organoides. Los hallazgos del equipo de EGRET-AAA mejorarán la calidad de vida de millones de enfermos en todo el mundo y reducirán la carga socioeconómica de la enfermedad.

Objetivo

EGRET-AAA is a joint doctorate program to provide training in glaucoma research, leading to joint doctoral degrees for 15 ESRs. It converts existing partnerships between universities into long-lasting ones. Together with many private and societal partners, our consortium forms a cradle for a European network of highly skilled, resilient, entrepreneurial and creative researchers, who will inspire each other to excel in glaucoma research, both during and long after the funding period.

EGRET-AAA will produce innovative treatments to protect and restore vision in patients with progressive eye disease glaucoma. By using revolutionary human retinal organoids, we will accelerate the development of new treatments and bring gene therapy and stem cell-based approaches a major step closer to clinical implementation, while minimizing the need for animal research. Through our findings, we will be able to protect the regenerated eye-brain connections and develop diagnostic techniques to select patients suitable for treatment and to evaluate intervention effects. By doing so, we will ultimately save approximately 1 million Europeans from blindness, and another 5 million from significant vision loss, thereby increasing their quality of life, and dramatically reducing societal and health care costs.

Through our interdisciplinary and inter-sectoral training, the 15 ESRs will gain essential skills and assets for success in a broad range of careers in academia and beyond. Based on our previous experience gained on multiple training networks, we believe that this timely program provides an in-depth graduate research training environment of unrivalled quality and pertinence, far greater and better than the sum of its parts. By anticipating continued demand for the skills and experience of our ESRs, we see EGRET-AAA as the precursor of a permanent and sustainable glaucoma-focused European doctoral program.

Ámbito científico

Palabras clave

Programa(s)

Tema(s)

Convocatoria de propuestas

HORIZON-MSCA-2021-DN-01

Consulte otros proyectos de esta convocatoria

Régimen de financiación

HORIZON-TMA-MSCA-DN-JD - HORIZON TMA MSCA Doctoral Networks - Joint Doctorates

Coordinador

ACADEMISCH ZIEKENHUIS GRONINGEN
Aportación neta de la UEn
€ 1 097 481,60
Dirección
HANZEPLEIN 1
9713 GZ Groningen
Países Bajos

Ver en el mapa
Región
Noord-Nederland Groningen Overig Groningen
Tipo de actividad
Higher or Secondary Education Establishments
Enlaces
Coste total
Sin datos

Participantes (6)

Socios (19)

Compartir esta página

Descargar

Última actualización: 4 Septiembre 2022

Mi folleto

Permalink: https://cordis.europa.eu/project/id/101072435/es

European Union, 2024